publication venue for
- TB and COVID-19 co-infection: rationale and aims of a global study. 25:78-80. 2021
- Provider perspectives on liberty and harm in the treatment of persons with tuberculosis and mental illness. 23:405-411. 2019
- Paediatric tuberculosis among the foreign-born: utility of the Canadian TB immigration medical surveillance programme. 23:105-111. 2019
- <I>CYP7A1</I>, <I>BAAT</I> and <I>UGT1A1</I> polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity. 20:812-818. 2016
- Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates. 18:787-792. 2014
- Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment. 15:421-421. 2011
- Tuberculosis and poverty: what could (and should) be done?. 14:1215-1221. 2010
- The impact of the method of consent on response rates in the ISAAC time trends study.. 14:1059-1065. 2010
- Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.. 10:1080-1090. 2006
- Management of chronic asthma in adults in diverse regions of the world.. 10:474-483. 2006
- Drug susceptibility of Mycobacterium tuberculosis in HIV-infected and -uninfected Ethiopians and its impact on outcome after 24 months of follow-up.. 8:1388-1391. 2004
- Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians.. 7:110-116. 2003
- Predictors of outcome in patients with tuberculous meningitis.. 6:64-70. 2002